Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Aptevo Therapeutics Inc. (APVO)

Income Statement Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Product sales        27.9
    Other        5.7
Total revenues   [+]12.34.30.023.114.710.033.6
            Revenue growth  185.3% -100.0%57.4%46.8%-70.3% 
Cost of goods sold  0.00.00.011.25.012.516.9
Gross profit  12.34.30.011.99.6-2.516.7
            Gross margin  100.0%100.0% 51.4%65.8%-24.9%49.6%
Selling, general and administrative   [+]14.714.016.228.134.636.243.0
Research and development  19.017.924.835.429.029.134.7
EBITDA   [+]-20.3-26.1-38.7-49.3-50.8-64.4-58.2
            EBITDA margin  -164.8%-605.4% -213.6%-346.7%-644.9%-173.2%
Depreciation  1.11.42.22.42.32.6-0.5
EBITA  -21.4-27.5-41.0-51.7-53.1-67.0-57.7
            EBITA margin  -174.1%-638.1% -224.0%-362.6%-670.6%-171.7%
Amortization of intangibles      0.80.83.4
EBIT   [+]-21.4-27.5-41.0-51.7-53.9-67.8-61.1
            EBIT margin  -174.1%-638.1% -224.0%-368.1%-678.6%-181.8%
Non-recurring items   [+]     71.0 
Other income (expense), net   [+]-8.0-3.4-2.1-2.0-1.9-0.8-0.2
Pre-tax income  -29.4-30.9-43.1-53.7-55.9-139.6-61.3
Income taxes  -1.0-13.2-2.60.0-23.3-19.7-2.0
            Tax rate  3.2%42.6%6.1%0.0%41.7%14.1%3.3%
Earnings from continuing ops  -30.4-44.1-45.7-53.7-72.2-127.4-59.3
Earnings from discontinued ops  1.013.22.6 39.67.5 
Net income  -29.4-30.9-43.1-53.7-32.6-119.9-59.3
            Net margin  -239.2%-717.6% -232.8%-222.3%-1200.7%-176.5%
   
Basic EPS   [+]($6.48)($13.00)($15.66)($2.39)($3.38)($6.29)($2.93)
Diluted EPS   [+]($6.48)($13.00)($15.66)($2.39)($3.38)($6.29)($2.93)
   
Shares outstanding (basic)   [+]4.73.42.922.521.320.220.2
Shares outstanding (diluted)   [+]4.73.42.922.521.320.220.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy